Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00056563 · ClinicalTrials.gov registry record · Phase 3

Phase I Deep Brain Stimulation (DBS) vs. Best Medical Therapy (BMT) Trial

A Phase 3 study, sponsored by US Department of Veterans Affairs.

Completed
Registry status
Phase 3
Development phase
255
Enrollment target

NCT00056563 is a Phase 3 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 255 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00056563, a Phase 3 study, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
Phase 3
Development phase
255 participants
Enrollment target

Study Summary

The goals of this study are to determine if simultaneous bilateral subthalamic nucleus stimulation or simultaneous bilateral globus pallidus stimulation is more effective in reducing symptoms of Parkinson's disease, and if deep brain stimulation or best medical therapy is more effective in improving Parkinson's disease symptoms

Interventions

  • DEVICE Bilateral Deep Brain Stimulation
  • OTHER best medical therapy

Trial Details

FieldValue
Enrollment Target 255 participants
Start Date 2002-04
Est. Completion 2008-10
Phase Phase 3

Sponsor

US Department of Veterans Affairs

632 total trials

What the Registry Record Tells You About NCT00056563

The ClinicalTrials.gov registry entry for NCT00056563 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 255 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Bilateral Deep Brain Stimulation is the first listed.

NCT00056563 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00056563 about?

NCT00056563 is a clinical study titled "Phase I Deep Brain Stimulation (DBS) vs. Best Medical Therapy (BMT) Trial". The goals of this study are to determine if simultaneous bilateral subthalamic nucleus stimulation or simultaneous bilateral globus pallidus stimulation is more effective in reducing symptoms of Parkinson's disease, and if deep brain stimulation or best medical therapy is more effective in improving...

What is the current status of trial NCT00056563?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 255 participants. The study started on 2002-04. Estimated completion is 2008-10.

What interventions are being tested in trial NCT00056563?

The interventions under investigation include: Bilateral Deep Brain Stimulation (DEVICE), best medical therapy (OTHER).

Who is sponsoring clinical trial NCT00056563?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.